Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder

Journal of Psychopharmacology

Volumn 24, Issue 4, 2010, Pages 521-529

  Hewett, K ^a   Chrzanowski, W ^b   Jokinen, R ^c   Felgentreff, R ^d   Shrivastava, R K ^e   Gee, M D ^a   Wightman, D S ^f   O'Leary, M C ^a   Millen, L S ^a   Leon, M C ^f   Briggs, M A ^a   Krishen, A ^f   Modell, J G ^f  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Psychiatric Clinic of Medical Academy Bialystok   (Poland)

^c Turku Psychiatric Clinic   (Finland)

^d Private Practice ^*  (Germany)

^e Eastside Compreh Medical Services   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Bupropion; Depression; Efficacy; Elderly; Health outcomes; Placebo controlled; Tolerability

Indexed keywords

AMFEBUTAMONE; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENERGY; FATIGUE; FEMALE; HUMAN; HYPERHIDROSIS; INSOMNIA; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOTIVATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; VERTIGO; XEROSTOMIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUSTRALIA; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; MALE; MOTIVATION; NORTH AMERICA; PERSONAL SATISFACTION; PLACEBO EFFECT; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950386766     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108100254     Document Type: Article

References (36)

1. Alexopoulos, GS, Vrontou, C., Kakuma, T., Meyers, BS, Young, RC, Klausner, E., et al. (1996) Disability in geriatric depression. Am J Psychiatry 153: 877-885. (Pubitemid 26225461)
2. Beaton, AE, Tukey, JW (1974) The fitting of power series, meaning polynomials, illustrated on bend-spectroscopic data. Technometrics 16: 147-185.
3. Beekman, AT, Copeland, JR, Prince, MJ (1999) Review of community prevalence of depression in later life. Br J Psychiatry 174: 307-311. (Pubitemid 29179713)
4. Blazer, DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58: 249-265. (Pubitemid 36307597)
5. Branconnier, RJ, Cole, JO, Ghazvinian, S., Spera, KF, Oxenkrug, GF, Bass, JL (1983) Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 44: 130-133. (Pubitemid 13088851)
6. Charney, DS, Reynolds 3rd, CF, Lewis, L., Lebowitz, BD, Sunderland, T., Alexopoulos, GS, et al. (2003) Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 60: 664-672. (Pubitemid 36818628)
7. Doraiswamy, PM, Khan, ZM, Donahue, RM, Richard, NE (2001) Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatry 9: 423-428.
8. Draper, BM, Koschera, A. (2001) Do older people receive equitable private psychiatric service provision under Medicare. Aust N Z J Psychiatry 35: 626-630. (Pubitemid 32982612)
9. Endicott, J. (2000) Quality of life enjoyment and satisfaction questionnaire (Q-LES-Q). In: Rush AJ, Handbook of psychiatric measures. Washington, DC: American Psychiatric Association, pp. 143-144.
10. Fava, M., Rush, AJ, Thase, ME, Clayton, A., Stahl, SM, Pradko, JF, et al. (2005) 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 7: 106-113. (Pubitemid 41783226)
11. Fehnel, SE, Bann, CM, Hogue, SL, Kwong, WJ, Mahajan, SS (2004) The development and psychometric evaluation of the Motivation and Energy Inventory (MEI). Qual Life Res 13: 1321-1336.
12. Fortner, MR, Brown, K., Varia, IM, Gersing, KR, OConnor, C., Doraiswamy, PM (1999) Effect of bupropion SR on the quality of life of elderly depressed patients with comorbid medical disorders. Prim Care Companion J Clin Psychiatry 1: 174-179.
13. Granger, AL, Fehnel, SE, Hogue, SL, Bennett, L., Edin, HM (2006) An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J Affect Disord 90: 217-221. (Pubitemid 43183531)
14. Huang, BY, Cornoni-Huntley, J., Hays, JC, Huntley, RR, Galanos, AN, Blazer, DG (2000) Impact of depressive symptoms on hospitalization risk in community-dwelling older persons. J Am Geriatr Soc 48: 1279-1284.
15. Jefferson, JW, Rush, AJ, Nelson, JC, VanMeter, SA, Krishen, A., Hampton, KD, et al. (2006) Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 67: 865-873. (Pubitemid 44049084)
16. Kasper, S., de Swart, H., Andersen, HF (2005) Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 13: 884-891. (Pubitemid 46638677)
17. Lebowitz, BD, Pearson, JL, Schneider, LS, Reynolds 3rd, CF, Alexopoulos, GS, Bruce, ML, et al. (1997) Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 278: 1186-1190.
18. Modell, JG, Rosenthal, NE, Harriett, AE, Krishen, A., Asgharian, A., Foster, VJ, et al. (2005) Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry 58: 658-667. (Pubitemid 41565581)
19. Quade, D. (1967) Rank analysis of covariance. J Am Stat Assoc 62: 1187-1200.
20. Rapaport, MH, Schneider, LS, Dunner, DL, Davies, JT, Pitts, CD (2003) Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 64: 1065-1074. (Pubitemid 37158252)
21. Roose, SP, Sackeim, HA, Krishnan, KR, Pollock, BG, Alexopoulos, G., Lavretsky, H., et al. (2004) Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 161: 2050-2059. (Pubitemid 39441406)
22. Schaefer, D., Pitts, C., Lipschitz, A., Iyengar, M. (2005) Efficacy and tolerability of fixed low dose paroxetine CR in the treatment of major depression in the elderly. American Psychiatric Association ; Abstract NR 701.
23. Schatzberg, AF, Cantillon, M. (2000) Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric patients with major depression. Eur Neuropsychopharmacol 10: S225 - S226.
24. Schneider, LS, Nelson, JC, Clary, CM, Newhouse, P., Krishnan, KR, Shiovitz, T., et al. (2003) An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160: 1277-1285. (Pubitemid 41070944)
25. Settle Jr, EC (1998) Bupropion sustained release: side effect profile. J Clin Psychiatry 59 (Suppl. 4). 32-36. (Pubitemid 28169257)
26. Sheehan, DV, Harnett-Sheehan, K., Raj, BA (1996) The measurement of disability. Int Clin Psychopharmacol 11 (Suppl. 3). 89-95. (Pubitemid 26373761)
27. Stahl, SM (2002) Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes. J Clin Psychiatry 63: 179-180.
28. Stahl, SM, Pradko, JF, Haight, BR, Modell, JG, Rockett, CB, Learned-Coughlin, S. (2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 6: 159-166.
29. Thase, ME, Clayton, AH, Haight, BR, Thompson, AH, Modell, JG, Johnston, JA (2006) A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol 26: 482-488.
30. Thase, ME, Haight, BR, Richard, N., Rockett, CB, Mitton, M., Modell, JG, et al. (2005) Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 66: 974-981. (Pubitemid 41191788)
31. Tollefson, GD, Bosomworth, JC, Heiligenstein, JH, Potvin, JH, Holman, S. (1995) A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr 7: 89-104.
32. Unützer, J., Patrick, DL, Diehr, P., Simon, G., Grembowski, D., Katon, W. (2000) Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr 12: 15-33. (Pubitemid 30180712)
33. Unützer, J., Patrick, DL, Simon, G., Grembowski, D., Walker, E., Rutter, C., et al. (1997) Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 277: 1618-1623. (Pubitemid 27231194)
34. Weihs, KL, Houser, TL, Batey, SR, Ascher, JA, Bolden-Watson, C., Donahue, RM, et al. (2002) Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biol Psychiatry 51: 753-761. (Pubitemid 34450811)
35. Weihs, KL, Settle Jr, EC, Batey, SR, Houser, TL, Donahue, RM, Ascher, JA (2000) Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 61: 196-202.
36. Zubenko, GS, Mulsant, BH, Sweet, RA, Pasternak, RE, Tu, XM (1997) Mortality of elderly patients with psychiatric disorders. Am J Psychiatry 154: 1360-1368. (Pubitemid 27415602)